Literature DB >> 20434134

Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain.

Magdalena M Brzózka1, Konstantin Radyushkin, Sven P Wichert, Hannelore Ehrenreich, Moritz J Rossner.   

Abstract

BACKGROUND: The combined analysis of several large genome-wide association studies identified the basic helix-loop-helix (bHLH) transcription factor TCF4 as one of the most significant schizophrenia susceptibility genes. Its function in the adult brain, however, is not known. TCF4 belongs to the E-protein subfamily known to be involved in neurodevelopment. The messenger RNA expression of Tcf4 is sustained in the adult mouse brain, suggesting a function in the adult nervous system. Tcf4 null mutant mice die perinatally, and haploinsufficiency of TCF4 in humans causes severe mental retardation.
METHODS: To investigate the possible function of TCF4 in the adult central nervous system, we generated transgenic mice that moderately overexpress TCF4 postnatally in the brain to reduce the risk of developmental effects possibly interfering with adult brain functions. Tcf4 transgenic mice were characterized with molecular, histological, and behavioral methods.
RESULTS: Tcf4 transgenic mice display profound deficits in contextual and cued fear conditioning and sensorimotor gating. Furthermore, we show that TCF4 interacts with the neurogenic bHLH factors NEUROD and NDRF in vivo. Molecular analyses revealed the dynamic circadian deregulation of neuronal bHLH factors in the adult hippocampus.
CONCLUSIONS: We conclude that TCF4 likely acts in concert with other neuronal bHLH transcription factors contributing to higher-order cognitive processing. Moderate transcriptional deregulation of Tcf4 in the brain interferes with cognitive functions and might alter circadian processes in mice. These observations provide insight for the first time into the physiological function of TCF4 in the adult brain and its possible contributions to neuropsychiatric disease conditions. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20434134     DOI: 10.1016/j.biopsych.2010.03.015

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  51 in total

Review 1.  Impact of TCF4 on the genetics of schizophrenia.

Authors:  Leonhard Lennertz; Boris B Quednow; Jens Benninghoff; Michael Wagner; Wolfgang Maier; Rainald Mössner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-09-20       Impact factor: 5.270

2.  Transcription factor 4 as an important determinant of gating function in schizophrenia.

Authors:  Panos Roussos
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-05       Impact factor: 11.205

Review 3.  Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

Authors:  Susan B Powell; Martin Weber; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2012

4.  Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory.

Authors:  Nitai C Hait; Laura E Wise; Jeremy C Allegood; Megan O'Brien; Dorit Avni; Thomas M Reeves; Pamela E Knapp; Junyan Lu; Cheng Luo; Michael F Miles; Sheldon Milstien; Aron H Lichtman; Sarah Spiegel
Journal:  Nat Neurosci       Date:  2014-05-25       Impact factor: 24.884

5.  The Intellectual Disability and Schizophrenia Associated Transcription Factor TCF4 Is Regulated by Neuronal Activity and Protein Kinase A.

Authors:  Mari Sepp; Hanna Vihma; Kaja Nurm; Mari Urb; Stephanie Cerceo Page; Kaisa Roots; Anu Hark; Brady J Maher; Priit Pruunsild; Tõnis Timmusk
Journal:  J Neurosci       Date:  2017-09-26       Impact factor: 6.167

6.  Associations between TCF4 gene polymorphism and cognitive functions in schizophrenia patients and healthy controls.

Authors:  Xianghua Zhu; Huang Gu; Zhen Liu; Zhansheng Xu; Xiongying Chen; Xiaochen Sun; Jinguo Zhai; Qiumei Zhang; Min Chen; Keqin Wang; Xiaoxiang Deng; Feng Ji; Chuanxin Liu; Jun Li; Qi Dong; Chuansheng Chen
Journal:  Neuropsychopharmacology       Date:  2012-11-09       Impact factor: 7.853

Review 7.  Kraepelin revisited: schizophrenia from degeneration to failed regeneration.

Authors:  P Falkai; M J Rossner; T G Schulze; A Hasan; M M Brzózka; B Malchow; W G Honer; A Schmitt
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

Review 8.  Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective.

Authors:  Boris B Quednow; Magdalena M Brzózka; Moritz J Rossner
Journal:  Cell Mol Life Sci       Date:  2014-01-12       Impact factor: 9.261

9.  Building a schizophrenia genetic network: transcription factor 4 regulates genes involved in neuronal development and schizophrenia risk.

Authors:  Hanzhang Xia; Fay M Jahr; Nak-Kyeong Kim; Linying Xie; Andrey A Shabalin; Julien Bryois; Douglas H Sweet; Mohamad M Kronfol; Preetha Palasuberniam; MaryPeace McRae; Brien P Riley; Patrick F Sullivan; Edwin J van den Oord; Joseph L McClay
Journal:  Hum Mol Genet       Date:  2018-09-15       Impact factor: 6.150

10.  TCF4 and GRM8 gene polymorphisms and risk of schizophrenia in an Iranian population: a case-control study.

Authors:  Javad Tavakkoly-Bazzaz; Asaad Azarnezhad; Negar Mousavi; Pouya Salehipour; Esmaeil Shahsavand Ananloo; Fatemeh Alizadeh
Journal:  Mol Biol Rep       Date:  2018-10-04       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.